Publications list for Dr Louise Cole

2012 | 2011 | 2009 | 2008

2012

   
  • Xiang, X., Gui, H., King, N., Cole, L., Wang, H., Xie, Q., Bao, S. (2012), IL-22 and non-ELR-CXC chemokine expression in chronic hepatitis B virus-infected liver. Immunology and Cell Biology. 90(6), 611-619. [Abstract]
  • Raviraj, V., Zhang, H., Chien, H., Cole, L., Thompson, E., Soon, L. (2012), Dormant but migratory tumour cells in desmoplastic stroma of invasive ductal carcinomas. Clinical and Experimental Metastasis. 29(3), 273-292. [Abstract]

2011

   
  • Gervásio, O., Phillips, W., Cole, L., Allen, D. (2011), Caveolae respond to cell stretch and contribute to stretch-induced signaling. Journal of Cell Science. 124(Pt 21), 3581-3590. [Abstract]
  • Weisbrodt, L., McKinley, S., Marshall, A., Cole, L., Seppelt, I., Delaney, A. (2011), Daily Interruption of Sedation in Patients Receiving Mechanical Ventilation. American Journal of Critical Care. 20(4), e90-e98. [Abstract]
  • Girgis, C., Cole, L., Champion, B. (2011), Bilateral adrenal haemorrhage in a critically ill patient. Critical Care and Resuscitation. 13(2), 123-124. [Abstract]
  • Girgis, C., Cole, L., Champion, B. (2011), Bilateral adrenal haemorrhage in a critically ill patient. Critical Care and Resuscitation. 13(2), 123-124. [Abstract]

2009

   
  • Bellomo, R., Cass, A., Cole, L., Finfer, S., Gallagher, M., Lo, S., McArthur, C., McGuinness, S., Myburgh, J., Norton, R., Scheinkestel, C., Su, S. (2009), Intensity of continuous renal-replacement therapy in critically ill patients. New England Journal of Medicine. 361(17), 1627-1638. [Abstract]
  • Bellomo, R., Cass, A., Cole, L., Finfer, S., Gallagher, M., Goldsmith, D., Myburgh, J., Norton, R., Scheinkestel, C. (2009), Screening and study enrolment in the Randomized Evaluation of Normal vs. Augmented Level (RENAL) Replacement Therapy Trial. Blood Purification. 27(2), 199-205. [Abstract]

2008

   
  • Bellomo, R., Cass, A., Cole, L., Finfer, S., Gallagher, M., Goldsmith, D., Myburgh, J., Norton, R., Scheinkestel, C. (2008), Design and challenges of the Randomized Evaluation of Normal versus Augmented Level Replacement Therapy (RENAL) Trial: high-dose versus standard-dose hemofiltration in acute renal failure. Blood Purification. 26(5), 407-416. [Abstract]